human immunodeficiency virus associated neuropathy
HIV infection itself is associated with multiple neuropathic syndromes (30% to 67% of patients), including axonal as well as acute and chronic demyelinating neuropathies, with distal, symmetric polyneuropathy being most common. Between 30% and 67% of HIV patients will develop a neuropathy. CD4 count and HIV viral load were previously thought to be risk factors, but recent studies do not substantiate this claim. Treatment with neurotoxic drugs such as didanosine, stavudine, and zalcitabine was previously associated with neuropathy, causing them to fall out of favor
